Ovation Science Inc.
OVATF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $14 | $17 | $18 | $16 |
| % Growth | -18.5% | -5% | 8.9% | – |
| Cost of Goods Sold | $8 | $0 | $0 | $3 |
| Gross Profit | $5 | $17 | $17 | $13 |
| % Margin | 39.7% | 99.9% | 97.9% | 79.7% |
| R&D Expenses | $0 | $0 | $0 | $1 |
| G&A Expenses | $135 | $140 | $125 | $20 |
| SG&A Expenses | $136 | $140 | $125 | $21 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | -$92 | $0 | $0 | $75 |
| Operating Expenses | $44 | $140 | $125 | $97 |
| Operating Income | -$130 | -$123 | -$107 | -$84 |
| % Margin | -959.9% | -741.4% | -613.4% | -522.9% |
| Other Income/Exp. Net | -$4 | -$10 | -$14 | $58 |
| Pre-Tax Income | -$134 | -$134 | -$122 | -$26 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$96 | -$134 | -$122 | -$26 |
| % Margin | -710% | -802.1% | -694.1% | -163.2% |
| EPS | -0.003 | -0.004 | -0.004 | -0.001 |
| % Growth | 28.9% | -8.6% | -400% | – |
| EPS Diluted | -0.003 | -0.004 | -0.004 | -0.001 |
| Weighted Avg Shares Out | 35,245 | 34,983 | 34,983 | 35,255 |
| Weighted Avg Shares Out Dil | 35,245 | 34,983 | 34,983 | 35,247 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $8 | $8 | $22 | $11 |
| Depreciation & Amortization | $0 | $1 | $1 | $0 |
| EBITDA | -$88 | -$126 | -$99 | -$16 |
| % Margin | -652.3% | -754.1% | -562.9% | -97% |